‌

US Patent 7420048 Human skeletal muscle-specific ubiquitin-conjugating enzyme

Patent 7420048 was granted and assigned to Otsuka Pharmaceutical on September, 2008 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

Otsuka Pharmaceutical

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

74200480

Patent Inventor Names

Tsutomu Fujiwara0

Masato Horie0

Takeshi Watanabe0

Date of Patent

September 2, 2008

Patent Application Number

103422760

Date Filed

January 15, 2003

Patent Primary Examiner

‌

Brian Whiteman

Patent abstract

An isolated and purified human skeletal muscle-specific ubiquitin-conjugating enzyme comprising the amino acid sequence shown in SEQ ID NO: 22 is disclosed. The use of the genes make it possible to detect the expression of the same in various tissues, analyze their structures and functions, and produce the human proteins encoded by the genes by the technology of genetic engineering. Through these, it becomes possible to analyze the corresponding expression products, elucidate the pathology of diseases associated with the genes, for example hereditary diseases and cancer, and diagnose and treat such diseases.